Literature DB >> 24653469

Expert conference on cancer pain assessment and classification--the need for international consensus: working proposals on international standards.

Stein Kaasa1, Giovanni Apolone, Pål Klepstad, Jon Håvard Loge, Marianne Jensen Hjermstad, Oscar Corli, Florian Strasser, Tarja Heiskanen, Massimo Costantini, Vittorina Zagonel, Mogens Groenvold, Robin Fainsinger, Mark P Jensen, John T Farrar, Henry McQuay, Nan E Rothrock, James Cleary, Catherine Deguines, Augusto Caraceni.   

Abstract

An increasing number of cancer patients live longer, and palliative care has become an important part of their treatment. Symptoms are often inadequately assessed and managed. A significant challenge in clinical trials is to control for the variability of the samples being studied. To overcome this problem, classification systems have been developed in order to characterise and stratify patients by grouping them according to major common characteristics. The lack of agreed methods for the assessment and classification of cancer pain has been clearly indicated in clinical trials and in clinical practice and may be one possible explanation for the inadequate treatment of cancer pain. This was the background to an international expert meeting arranged in September 2009 in Milan, Italy. The primary aims were to produce recommendations on how to assess and classify cancer pain and to recommend a strategy for the further development, validation and implementation of an international cancer pain classification and assessment system. The recommendations consisted of two basic working proposals, nine specific working proposals and seven recommendations for the further development of a cancer pain classification system. Examples of specific working proposals were to include pain intensity, pain mechanism, breakthrough pain and psychological distress as the core domains in this classification of cancer pain and to measure pain intensity with a 0-10 numerical rating scale with 'no pain' and 'pain as bad as you can imagine' as anchors. The proposed name for this international standard is Cancer Pain Assessment and Classification System (CPACS).

Entities:  

Mesh:

Year:  2011        PMID: 24653469     DOI: 10.1136/bmjspcare-2011-000078

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  14 in total

Review 1.  Pharmacological options for the management of refractory cancer pain-what is the evidence?

Authors:  B Afsharimani; K Kindl; P Good; J Hardy
Journal:  Support Care Cancer       Date:  2015-03-07       Impact factor: 3.603

2.  A philosophical critique of the UK's National Institute for Health and Care Excellence guideline 'Palliative care for adults: strong opioids for pain relief'.

Authors:  David Fearon; Sean Hughes; Sarah G Brearley
Journal:  Br J Pain       Date:  2018-01-10

3.  Comparative responsiveness of pain measures in cancer patients.

Authors:  Kurt Kroenke; Dale Theobald; Jingwei Wu; Wanzhu Tu; Erin E Krebs
Journal:  J Pain       Date:  2012-07-15       Impact factor: 5.820

4.  Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?

Authors:  Morten Thronæs; Trude Rakel Balstad; Cinzia Brunelli; Erik Torbjørn Løhre; Pål Klepstad; Ola Magne Vagnildhaug; Stein Kaasa; Anne Kari Knudsen; Tora Skeidsvoll Solheim
Journal:  Support Care Cancer       Date:  2019-07-09       Impact factor: 3.603

5.  Assessing the response to opioids in cancer patients: a methodological proposal and the results.

Authors:  O Corli; A Roberto; M T Greco; M Montanari
Journal:  Support Care Cancer       Date:  2014-12-05       Impact factor: 3.603

6.  Canadian recommendations for the management of breakthrough cancer pain.

Authors:  P Daeninck; B Gagnon; R Gallagher; J D Henderson; Y Shir; C Zimmermann; B Lapointe
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

7.  A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis.

Authors:  A Roberto; M T Greco; L Legramandi; F Galli; M Galli; O Corli
Journal:  J Pain Res       Date:  2017-09-04       Impact factor: 3.133

8.  Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.

Authors:  Roger von Moos; Jean-Jacques Body; Blair Egerdie; Alison Stopeck; Janet E Brown; Danail Damyanov; Lesley J Fallowfield; Gavin Marx; Charles S Cleeland; Donald L Patrick; Felipe G Palazzo; Yi Qian; Ada Braun; Karen Chung
Journal:  Support Care Cancer       Date:  2013-08-22       Impact factor: 3.603

9.  Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.

Authors:  Marzia Lazzari; Maria Teresa Greco; Claudio Marcassa; Simona Finocchi; Clarissa Caldarulo; Oscar Corli
Journal:  Drug Des Devel Ther       Date:  2015-11-02       Impact factor: 4.162

10.  Characteristics and prognostic factors for pain management in 152 patients with lung cancer.

Authors:  Lei Shi; Yumei Liu; Hua He; Cong Wang; Hongwei Li; Nanya Wang
Journal:  Patient Prefer Adherence       Date:  2016-04-15       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.